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Objective: Cigarette smoking had been confirmed as an increased risk for dyslipidemia, but none of the evidence
was from long-lived population. In present study, we detected relationship between cigarette smoking habits and
serum lipid/lipoprotein (serum Triglyceride (TG), Total cholesterol (TC), Low-density lipoprotein (LDL) and
high-density lipoprotein (HDL)) among Chinese Nonagenarians/Centenarian.
Methods: The present study analyzed data from the survey that was conducted on all residents aged 90 years or
more in a district, there were 2,311,709 inhabitants in 2005. Unpaired Student’s t test, χ2 test, and multiple logistic
regression were used to analyze datas.
Results: The individuals included in the statistical analysis were 216 men and 445 women. Current smokers had
lower level of TC (4.05 ± 0.81 vs. 4.21 ± 0.87, t= 2.403, P = 0.017) and lower prevalence of hypercholesteremia
(9.62% vs. 15.13%, χ2 = 3.018,P = 0.049) than nonsmokers. Unadjusted and adjusted multiple logistic regressions
showed that cigarette smoking was not associated with risk for abnormal serum lipid/lipoprotein.
Conclusions: In summary, we found that among Chinese nonagenarians/centenarians, cigarette smoking habits
were not associated with increased risk for dyslipidemia, which was different from the association of smoking habits
with dyslipidemia in general population.
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Dyslipidemia was the presence of abnormal levels of lipids
in the blood, characterized by an elevation of the concentra-
tion of total cholesterol (TC), low-density lipoprotein
(LDL), and triglycerides (TG), and a decrease in high-
density lipoprotein cholesterol (HDL) [1,2]. Smoking was a
major risk factor for atherosclerotic cerebro- and cardiovas-
cular diseases (CVD) through leading to dyslipidemia [3]. A
comprehensive meta-analysis by Craig et al. examined pub-
lished data from 1966 to 1987 and estimated the excess risk
posed by smoking on CVD, with particular emphasis on
lipid and lipoprotein involvement [1]. Results of their ana-
lysis indicated that compared with non-smokers, cigarettes
smokers had significantly higher TC (3%), TG (9.1%), and* Correspondence: birongdong@163.com
Department of Geriatrics, West China Hospital, Sichuan University,
Guoxuexiang 37, Chengdu, Sichuang province, China 610041
© 2012 Yan-Ling et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the orLDL (10.4%), higher (but not significant LDL (1.7%), and
lower concentrations of HDL (−5.7%) [1]. In the meta-
analysis, a dose–response relationship was found between
the number of cigarettes smoked and the change in lipid
or lipoprotein variable [1]. The results indicated a progres-
sive increase (%) as the smoking dosage increased from
none to heavy: TC (0, +0.8, +4.3 and +4.5%), TG (0, +10.7,
+11.5 and +18.0%), LDL (0, +7.2, +44.4, and +39.0%), and
LDL (0, −1.1, −1.4 and +11.0%). They also reported dose
related decreases in HDL (0, −4.6, −6.3, −8.9%) [1].
Many physiologic benefits were associated with smoking
cessation, including normalization of the lipid and lipo-
protein profile. A meta-analysis by Maeda et al. suggested
that with smoking cessation an individual could experi-
ence an increase in HDL, but other lipid and lipoproteins
(TC, LDL, and TG) remained unchanged [4]. Movement
toward normalization of HDL could be seen in as little as
17 days and would continue to progress toward normalal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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results had important implications, because they would
alter the ratios of HDL, TC, HDL and LDL and could pro-
mote clearance of cholesterol from the circulation [4].
The relationship between dyslipidemia and smoking,
smoking dosage or smoking cessation had been con-
firmed by sufficient evidence [5-8]. There was a high
smoking rates in China, especially in elderly men, and
several millions old people die from smoking-related dis-
eases and dyslipidemia-related diseases in china. Smok-
ing and dyslipidemia synergy to accelerate the death,
there might be a difference relationship between smok-
ing and dyslipidemia, clearing the relationship might be
important for increasing the proportion of the longevity
in population and for improving the health status of the
longevity of the elderly. However, all the evidences on
association of dyslipidemia with smoking habits were
from general population. So it still had been unclear that
whether the relationship existed in long-lived subjects or
not. In the present study, using data from a sample of
Chinese nonagenarians and centenarians, we examined
the association between hypertension and dyslipidemia
in the long-lived subjects.
Subjects and methods
Study subjects
The methods were reported previously [9-11]. In brief,
on the basis of the Dujiangyan (located in Sichuan prov-
ince, southwest China) 2005 census, a cross-sectional
study for age-related diseases was conducted in 870
long-lived subjects (>90 years), which was a part of the
Project of Longevity and Aging in Doujiangyan (PLAD).
The PLAD aimed to investigate the relationship between
environments, lifestyle, genetic, longevity and age-
related diseases. Volunteers were examined by trained
professional physicians according to basic health criteria.
And the results were filled in the standard form. In this
analysis, the subjects, who had no biological specimen for
measurement levels serum Lipid/Lipoprotein, or reported
the use of drugs affecting the serum lipid/lipoprotein levels,
or no information on smoking habits were excluded. The
study population ultimately consisted of 661 long-lived
subjects. Informed consents were obtained from all partici-
pants (as well as their legal proxies). The Research Ethics
Committee of the Sichuan University approved the study.
Data collection and measurements
Measurement of serum lipid/lipoprotein and fasting
blood glucose (FBG)
The methods were reported previously [10,11]. Blood sam-
ples were collected after an overnight fast (at least 8 h) for
measurement of serum lipid/lipoprotein. Lipid/lipoprotein
levels including serum Triglyceride (TG), TC, Low-density
lipoprotein (LDL) and High-density lipoprotein (HDL) weredetermined by standard laboratory techniques. Cholesterol
and triglyceride levels were measured by commercially
available enzymatic kits (Roche, Mannheim, Germany)
[12,13]. FBG was also determined by the standard labora-
tory techniques [12,13]. FBG was assessed using a glucose
oxidase assay [14]. Lipid/lipoprotein levels and FBG was
performed by a technician in the biochemistry laboratory
of Sichuan University. Abnormal levels of serum lipid/
lipoprotein were defined according to the criteria provided
by the Chinese Medical Association 2004. Abnormal cri-
teria were: TC >5.18 mmol/l, TG >1.7 mmol/l, LDL
>3.37 mmol/l and HDL <1.04 mmol/l [15].
Cigarette smoking
Information on smoking habits was inquired using the
questionnaire designed according to the previous studies
[8,16-18]. Participants was classified the following groups
according to the questionnaire [19,20]: 1) nonsmokers: indi-
viduals who reported never having a cigarette; 2) smokers:
individuals who reported smoking every day now and hav-
ing the habit for more than 6 months; for smokers, the
smoking dose was questioned: how many cigarette smoking
was taken and the smokers were grouped as follows: light
(1–4 cigarette per day), medium (5–9 cigarette per day),
heavy (above 10 cigarette per day). 3) With a history of
smoking: individuals who had smoking for at least 6 months
and including those smoking former and current; 4) smok-
ing cessation: individuals who had quit smoking for at least
6 months; Participants who smoked intermittently (0 or 1
cigarette per day) were not included in the study.
Statistical analysis
All of the statistical analyses for this study were performed
with the SPSS for Windows software package, version11.5
(SPSS Inc, Chicago, Illinois, USA). Serum lipid/lipoprotein
levels and prevalence of abnormal levels of serum lipid/
lipoprotein were compared between smokers and non-
smokers, or among groups with different smoking dosage,
or with and without history of smoking, or with and with-
out smoking cessation using χ2 or Fisher’s exact test
(where an expected cell count was < 5) for categorical
variables and unpaired Student’s t test for continuous vari-
ables. Multiple logistic regression was used to estimate the
odds ratio (OR) and 95% confidence interval (CI) of
current smoking and smoking cessation as a function of
increased abnormal levels of serum lipid/lipoprotein.
P value <0.05 was considered to be statistically significant,
and all of the P values have two sides.
Results
Prevalence of abnormal serum lipid/lipoprotein and
smoking habits
Among the 661 participants, mean age was 93.51 years, 69
were centenarians and 445 were women. Ninety percent
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individuals with history of smoking (60.67%), including
128 (19.36%) individuals with smoking cessation and 273
(41.30%) current smokers. The mean of FBG was 4.64 (s.
d.:1.45). In those current smokers, 146 (53.48%), 90
(32.97%) and (13.55%) were in the light, medium and
heavy dosage groups, respectively. Among the sample,
men had more current smokers (64.16%% vs. 15.96%,
χ2 = 87.88, P≤ 0.001) and more with history of smoking
(78.76% vs. 50.11%, χ2 = 63.12, P≤ 0.001) than women.
Among the sample, the means of serum Lipid/Lipo-
protein were 4.15 (s.d.:0.85) mmol/L, 1.22 (s.d.:0.64)
mmol/L, 2.28 (s.d.:0.97) mmol/L, 1.58 (s.d.:0.59) mmol/L
for TC, TG, LDL and HDL, respectively. The prevalence
of abnormal serum Lipid/Lipoprotein were 75 (11.3%),
89 (13.5%), 35 (5.3%) and 37 (5.6%) according to TC,
TG, LDL and HDL, respectively. (See Tables 1 and 2).
Current smokers had a lower TC serum level and a lower
a prevalence of abnormal TC than nonsmokers, but no
difference in the other serum lipid/lipoprotein levels and
the prevalence abnormal of those
We examined the difference of serum Lipid/Lipoprotein
and prevalence of abnormal serum Lipid/Lipoprotein be-
tween smokers and nonsmokers. The result showed that
current smokers had a lower level of serum TC (4.05±0.81
vs. 4.21±0.87, t=2.403, P=0.017), and lower prevalence of
abnormal TC(9.62% vs. 15.13%,χ2 = 3.018,P= 0.049) than
nonsmokers. However, none of the difference in the serum
TG, LDL and HDL levels was significant between current
smokers and nonsmokers (1.21±0.56 vs. 1.23±0.69,Table 1 Comparing the age, gender, FBG and serum lipid/lipo
non-smoking habit, and among groups with different smokin
Characteristics Smoking status
Smoker n= 273 Non-smoker n = 388 χ2 or t P valu
Age (years) 93.37 ± 3.22 93.62 ± 3.47 0.944 0.346
Gender a
(Male/Female) 145/128 71/317 87.88 ≤0.001
TG (mmol/L) 1.21 ± 0.56 1.23 ± 0.69 0.492 0.623
TC (mmol/L) 4.05 ± 0.81 4.21 ± 0.87 2.403 0.017
HDL (mmol/L) 1.54 ± 0.62 1.60 ± 0.56 1.224 0.222
LDL (mmol/L) 2.21 ± 0.55 2.28 ± 0.63 1.443 0.149
FBG (mmol/L) 4.43 ± 1.58 4.48 ± 1.36 0.389 0.697
Abnormal Serum Lipid/Lipoprotein
TG 33/240 56/332 0.756 0.226
TC 24/249 51/337 3.019 0.049*
HDL 19/254 18/370 1.633 0.135
LDL 10/263 25/363 2.470 0.080
Comparing the age, gender, FBG and Serum Lipid/Lipoprotein between subjects wi
quantity, Using χ2 or Fisher’s exact test (wherea an expected cell count was < 5) for
the testing, a P value< 0.05 was considered to be statistically significant. * P< 0.05
density lipoprotein; TC: Total cholesterol; TG: Triglyceride.t=0.492, P=0.623 for TG; 2.21±0.55 vs. 2.28±0.63,
t=1.443, P= 0.149 for LDL; 1.54±0.62 vs. 1.60±0.56,
t=1.224., P = 0.222 for HDL). None of the difference in
prevalence of abnormal TG, LDL and HDL levels was sig-
nificant between current smokers and nonsmokers (12.09%
vs. 16.87%, χ2 = 0.756,P=0.226 for TG; 3.80% vs. 6.88%,
χ2 = 2.470,P=0.080 for LDL; 7.48% vs. 4.86%, χ2 = 1.633,
P=0.135 for HDL). Current smokers showed no signifi-
cantly higher risk for prevalence of abnormal Lipid/Lipo-
protein. (See Tables 1 and 3).None of difference in serum lipid/lipoprotein levels and
the prevalence of abnormal those between subjects with
and without smoking history, among groups with
different smoking dosage, and between subjects with and
without smoking cessation
We further examined the effect of smoking history (in-
cluding current and former smokers), smoking dosage
and smoking cessation on serum Lipid/Lipoprotein
levels and the prevalence of abnormal those serum
Lipid/Lipoprotein levels. The result showed none differ-
ence in serum Lipid/Lipoprotein (including TG, TC,
LDL and LDL) and the prevalence of abnormal those
(including TG, TC, LDL and LDL) was significant be-
tween individuals with and without smoking history,
among different smoking dosage and between indivi-
duals with and without smoking cessation. There was
also no significant difference in risk for the increased
prevalence of abnormal those serum Lipid/Lipoprotein
levels. (See Tables 2 and 3).protein between subjects with smoking and
g quantity (n = 661)
Smoking dosage
e Light n = 146 Medium n=90 Heavy n= 37 χ2 or F P value
93.52 ± 3.20 93.23 ± 3.13 93.11 ± 3.56 0.362 0.697
* 65/81 58/32 22/15 9.567 0.008*
1.20 ± 0.52 1.24 ± 0.63 1.16 ± 0.56 0.327 0.721
4.07 ± 0.75 4.11 ± 0.90 3.82 ± 0.77 1.778 0.171
1.49± 1.54± 1.52± 1.716 0.182
2.23 ± 0.55 2.23 ± 0.57 2.06 ± 0.49 1.535 0.217
4.39 ± 1.54 4.45 ± 1.53 4.58 ± 1.82 0.218 0.814
16/130 11/79 6/31 0.770 0.680
11/135 11/79 2/35 2.138 0.350
11/135 6/84 2/35 0.224 0.894
5/141 5/85 0/37 2.344 0.310
th smoking and non-smoking habit, and among groups with different smoking
categorical variables and unpaired Student’s t test for continuous variables. In
** P< 0.01. FBG, fasting blood glucose; HDL, high density lipoprotein; LDL, low
Table 2 Comparing the age, gender, FBG and serum lipid/lipoprotein between subjects with history of smoking and
non-smoking, and between subjects with different smoking cessation (n= 661)
Characteristics With history of smoking Smoking cessation
Yes n = 401 No n=260 χ2 or t P value Yes n = 128 No n=273 χ2 or MD P value
Age (years) 93.41 ± 3.29 93.67 ± 3.49 0.980 0.327 93.50 ± 3.45 93.37 ± 3.22 93.62 ± 3.47 0.944
Gender a
(Male/Female) 178/223 38/222 63.120 ≤0.001* 33/95 145/128 71/316 87.88
TG (mmol/L) 1.20 ± 0.63 1.26 ± 0.66 1.185 0.236 1.18 ± 0.75 1.21 ± 0.56 1.23 ± 0.69 0.492
TC (mmol/L) 4.11 ± 0.83 4.20 ± 0.88 1.333 0.183 4.24 ± 0.86 4.05 ± 0.81 4.21 ± 0.87 2.403
HDL (mmol/L) 1.55 ± 0.55 1.61 ± 0.64 1.301 0.191 1.57 ± 0.37 1.54 ± 0.62 1.60 ± 0.56 1.224
LDL (mmol/L) 2.24 ± 0.58 2.27 ± 0.63 0.663 0.508 2.21 ± 0.63 2.21 ± 0.55 2.28 ± 0.63 1.443
FBG (mmol/L) 4.49 ± 1.57 4.43 ± 1.25 0.483 0.630 4.59 ± 1.55 4.43 ± 1.58 4.48 ± 1.36 0.389
Hypertriglyceridemia 49/352 40/220 1.356 0.147 16/112 33/240 56/332 0.756
Hypercholesteremia 42/359 33/227 0.772 0.360 18/110 24/249 51/337 3.019
Lower HDL 25/376 12/248 0.782 0.240 6/122 19/254 18/370 1.633
Higher LDL 20/381 15/345 0.192 0.363 10/118 10/263 25/363 2.470
* P< 0.05 ** P< 0.01 vs. Using χ2 or Fisher’s exact test (wherea an expected cell count was < 5) for categorical variables and unpaired Student’s t test for
continuous variables. In the testing, a P value< 0.05 was considered to be statistically significant. FBG, fasting blood glucose; HDL, high density lipoprotein; LDL,
low density lipoprotein; TC: Total cholesterol; TG: Triglyceride.
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This study evaluated the effect of smoking habits (includ-
ing current smoker, smoking history, smoking dosage and
smoking cessation) on serum Lipid/Lipoprotein (including
TG, TC, LDL and HDL). Current smoker had lowerTable 3 Effect of smoking and smoking cessationon abnorma
Characteristics Smoking
With/without (273/388) OR 95%
TC
















OR, odds ratio. Unadjusted: Wald Chi-square test with df = 1 was used; Adjusted m
blood glucose; HDL, high density lipoprotein; LDL, low density lipoprotein; TC: Totaserum TC and lower risk for abnormal serum TC. The
serum lower serum TC and lower risk for abnormal serum
TC did not exist in individuals with smoking history,
heavy smoking dosage and smoking cessation. Smoking
habits did not have effect on serum TG, LDL and HDL.l serum lipid/lipoprotein in long-lived subjects
Smoking cessation













ultiple logistic regression was used to adjust for age, gender, FBG. FBG, fasting
l cholesterol; TG: Triglyceride.
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had lower level of TC and lower prevalence of abnormal
TC [21-27]. This indicated that current smoking was asso-
ciated with low serum TC levels, but none of difference in
TC levels and prevalence of abnormal TC was significant
difference among individuals with different smoking dos-
age. All of these results indicated that effect of smoking
habits on serum TC was independent on smoking dosage.
Previous studies confirmed that in general population,
current smoking increased TC levels and prevalence of ab-
normal TC, heavy smoking was associated with increased
TC and higher risk for abnormal TC, and smoking cessa-
tion was associated with decreased TC and decreased risk
for abnormal TC. Our result showed that the relationship
between smoking habits and serum TC in long-lived sub-
jects was different that in general population. This was an
interesting finding. Mechanisms of difference could be
explained by the following. In Chinese, mean life span was
77 years in 2011, in the present study, the all participants
were all above 90 years. In the elderly, with aging, mortal-
ity rate increased. Smoking habits led to high TC in gen-
eral adult. Smoking habits and hypercholesteremia were
both definitive risk for cerebrovascular disease. Smoking
habits and hypercholesteremia were also the confirmed
risk for dementia, depression, disability and so on, all of
these increased mortality rate in the elderly above 65 years
[28,29]. The high mortality in the elderly could remove
those with hypercholesteremia, which was caused by
current smoking. This mean those with both habits of
current smoking and hypercholesteremia were more pos-
sibly removed by the high mortality in the elderly, and left
individuals with lower TC in current smokers. This led to
a lower TC level in current smokers, compared non-
smokers. This only a reasonable inference, which should
be further confirmed using prospective cohort study.
To the best of our knowledge, this was the first research
which focused on the association of smoking habits (includ-
ing current smokers, with history of smokers, with different
smoking dosage and smoking cessation) and serum Lipid/
Lipoprotein among Nonagenarians/Centenarians. This study
showed there was different in the association. Previous stud-
ies showed that current smoking and heavy dosage of smok-
ing were both associated with increased TG, TC and LDL,
and with decreased HDL. Smoking cessation could reverse
the effect of smoking on serum Lipid/Lipoprotein [21-27].
The results of the present study were different that from
those previous studies. In previous studies, the participants
were not all long-lived subjects, but in the present, all parti-
cipants were Nonagenarians/Centenarians. Longevity was
multifactorial consequence, including genetic and environ-
ment factors. Genetic factors, which related with longevity,
might include lipid metabolism gene, or include the gene,
which could ant-disadvantage of smoking [28-30]. The gen-
etic factor of longevity might have the function ant-disadvantage of smoking, including the effect of smoking on
serum Lipid/Lipoprotein. This was also a reasonable infer-
ence, which should be further confirmed using experiment.
The present study showed that in long-lived subjects,
smoking habits (current and former) were not associated
with dyslipidemia, on the other hand, current smoker had
lower TC and lower prevalence of abnormal TC. It had
been confirmed that smoking habits (current and former)
were definite risk factors of dyslipidemia. Therefore, from
the results of the study, it could not conduct that in long-
lived subjects smoking habits (current and former) were
not risk factors for dyslipidemia, or that smoking habits
(current and former) were prophylactic factors for dyslipi-
demia. As explanation above, longevial genetic factors
included which might have the function ant-disadvantage
of smoking, including the effect of smoking on serum
Lipid/Lipoprotein. These genetic factors were still un-
known, and it might be a field of research on Longevity.
Our study had some limitations that deserve a mention.
First, 870 subjects aged 90 years or older volunteered for
the PLAD Study, among these 870 volunteers, only 661 had
non-missing data for the two main variables involved in the
current analyses. There might be selection biases. Second,
because of the cross-sectional nature of this study, we only
concluded the association between smoking habits and
serum Lipid/Lipoprotein. We could not conduct causal
conclusions on it. Third, since this is a part of the PLAD,
there might be a survival bias. However, this is inherent in a
study of individuals of this age group. Forth, because of the
cross-sectional nature of this study, the subjects might
change their diets and the conditions related to elevated
serum lipid concentrations. However, the lifestyles and food
habits of the nonagenarians/centenarians were relatively
stable and similar. Fifth, inflammation seems to be the me-
diator of most of the issues related to chronic disease. It
would help provide some insight rather than just speculat-
ing. However, the data were all from a survey conducted in
2005, the data could not included inflammatory factor. Fi-
nally, there subjects with smoking habits in men had more
than those in women. Gender might influence the associ-
ation of smoking habits with serum Lipid/Lipoprotein. Data
analyzed according to gender might remove the influence.
There only 661 participants, we analyzed data according to
gender, none of the serum Lipid/Lipoprotein among differ-
ent smoking habits had significant different, so this caused
the sample size too small and could not obtain a conclu-
sion. Therefore, we reported results using the total sample,
not according to gender.
In conclusion, among longevity Chinese, only current
smoking was related with low TC levels. But the smoking
habits were not associated with the other serum Lipid/Lipo-
protein. The relationship between smoking habits and
serum Lipid/Lipoprotein in long-lived subjects was different
from that in general adults.
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